Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine  (#301)

6:00 PM

Syed Faraz Ahmed

The overlap between lipid droplets and extracellular vesicles in viral infection (#303)

6:00 PM

Irumi I Amarasinghe

PacBio HiFi Sequencing of the entire 16S rRNA gene reveal differences in the oral bacterial communities of healthy men and women infected with oral human papillomavirus infection (#305)

6:00 PM

Annika Antonsson

Emerging infectious diseases (#307)

6:00 PM

Vasso Apostolopoulos

Investigating disease progression in a large animal model of pulmonary fibrosis (#311)

6:00 PM

Rob Bischof

Inhibition of type I interferon signalling during Shigella flexneri infection (#313)

6:00 PM

Anita A Chaulagain

Development of vaccines against gonococcal disease using the PilVax platform (#315)

6:00 PM

Mejo Chiratteparambil Korah

Identification and characterisation of Cryptosporidium effector proteins in host-pathogen interaction (#317)

6:00 PM

Lena Chng

Specific gut microbiota modulates intestinal epithelial cell signalling and inflammation (#319)

6:00 PM

Michelle Chonwerawong

Characterisation of novel cytokine interferon epsilon in the murine peritoneal cavity in the context of high-grade serous ovarian cancer (#321)

6:00 PM

Jasmine Chuah

Characterising commensal and pathogenic staphylococcal interactions with neonatal and adult blood (#323)

6:00 PM

Andrew Currie

Rapid point of care self-test for diagnosis of active syphilis  (#325)

6:00 PM

Heidi E Drummer

Inhibitory activity of lactic acid isomers against L. iners and BV-associated vaginal bacteria   (#327)

6:00 PM

Paula Ellenberg

MicroRNA sepsis biomarkers: distinguishing bacterial aetiology from non-infectious inflammation in critically ill Australian patients (#329)

6:00 PM

Ryan J Farr

Aryl N-acetamides compounds exert antimalarial activity by acting as agonists of rhomboid protease PfROM8 and cation channel PfCSC1. (#331)

6:00 PM

Paul Gilson

Distribution of phenotypic antimicrobial resistance in the gastrointestinal microbiome. (#333)

6:00 PM

Emily L. Gulliver

Targeted microbiome remodelling as therapeutic interventions for gastrointestinal diseases (#335)

6:00 PM

Suet Li Hooi

Evaluation of antimicrobial and antibiofilm properties of novel synthetic antimicrobial peptides (#337)

6:00 PM

Taghrid Istivan

Development of antisense therapeutics for psoriasis (#339)

6:00 PM

Sulev Koks

A precision serology evaluation of a Swedish preeclampsia cohort verifies a link between CagA Helicobacter pylori infection and development of preeclampsia  (#341)

6:00 PM

Soraya Leedham

Phocaeicola dorei abundance is discriminatory between health and endometriosis in Australian women (#343)

6:00 PM

Yenkai Lim

Bacterial membrane vesicles promote horizontal gene transfer in Helicobacter pylori (#345)

6:00 PM

Christopher McCrory

Tracing the plasma proteomic and metatranscriptomic response to cladribine treatment in multiple sclerosis. (#349)

6:00 PM

Sam WZ Olechnowicz

A new model to test the direct delivery of aerosolised therapeutics to human airway cells – improving treatments for respiratory viruses (#351)

6:00 PM

Elizabeth A Pharo

Seasonal antigenic prediction of influenza A H3N2 using machine learning (#353)

6:00 PM

Ahmed Abdul Quadeer

Fitness landscape and evolutionary models for combating Hepatitis C virus (#355)

6:00 PM

Ahmed Abdul Quadeer

Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data (#357)

6:00 PM

Ahmed Abdul Quadeer

Combination of redox modifiers with artemisinin results in increased parasite susceptibility to artemisinins (#359)

6:00 PM

Annie Roys

Rabies Disease: Defining antigenic requirements for pan-lyssavirus neutralisation  (#361)

6:00 PM

Rebecca Shipley